Our previous research has shown that oral administration of miRCCL22 using S. typhimurium as a vector significantly reduced CCL22 gene expression in the mouse spleen and thereby induced immune-modulatory effects in an AD-like mouse model [21]. Here, CCL22 is linked to Alzheimer disease.